Skip to main content

Table 2 Main metastasis sites in patients with gastric cancer

From: CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence

Metastasis site

n = 127 (%)

Without evidence

75 (59.1%)

Liver

19 (15%)

Lung

11 (8.7%)

Retroperitoneum

4 (3.1%)

Ovary

4 (3.1%)

Colon

3 (2.4%)

Adrenal gland

3 (2.4) %)

Bone

2 (1.6%)

Mediastinum

2 (1.6%)

Distant abdominal nodes

2 (1.6%)

Pancreas

1 (0.8%)

Spleen

1 (0.8%)